| LncRNA Information | ||||||
|---|---|---|---|---|---|---|
| ID | EL0354 | Name | DNM3OS | Aliases | DNM3-AS1; MIR199A2HG | |
| Species | Homo sapiens | Chromosome | 1 | Start site | 172136531 | |
| End site | 172144794 | Chain | minus | Exon NO. | 4 | |
| Assembly | Ensembl Release 89 | Class | antisense | NCBI accession | NR_103486, NR_038397 | |
| Ensembl | ENSG00000230630 | Sequence | ||||
| Disease | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
| epithelial ovarian cancer | qPCR etc. | cell lines (type I, type II etc.) | up-regulated | locus | pri-miR-199a2 within the human Dnm3os gene. The regulation of MIR199A2/214 expression may be used as a potential therapeutic approach in EOC (epithelial ovarian cancer) patients. | 20400975 | LncRNADisease Lnc2Cancer | ||
| Interaction | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Interaction target | Level of interaction | Type of interaction | Description | PMID | Source | ||||
| TWIST1 | DNA-TF | regulation | Twist-1 regulates the miR-199a/214 cluster during development. | 19029138 | LncRNADisease | ||||